Showing results (2211-2220 of 27,712) with videos related to

Sort By:
Pageof 2,772
Vaccine|November 27, 2002
Vaccination with an adenoviral vector encoding hepatitis C virus (HCV) NS3 protein protects against infection with HCV-recombinant vaccinia virusLaura Arribillaga, Ascensión López Díaz de Cerio, Pablo Sarobe, et al.
Vaccine|November 27, 2002
Infection of mouse bone marrow-derived dendritic cells with recombinant adenovirus vectors leads to presentation of encoded antigen by both MHC class I and class II molecules-potential benefits in vaccine designOsquel Barroso Herrera, Sara Brett, Robert I Lechler
Vaccine|November 27, 2002
DNA vaccination with linear minimalistic (MIDGE) vectors confers protection against Leishmania major infection in miceL López-Fuertes, E Pérez-Jiménez, A J Vila-Coro, et al.
Vaccine|November 27, 2002
The generation and characterization of potentially therapeutic Abeta antibodies in mice: differences according to strain and immunization protocolEdward T Spooner, Roanak V Desai, Chica Mori, et al.
Vaccine|November 27, 2002
The use of Flt3 ligand as an adjuvant for hepatitis B vaccination of healthy adultsThomas G Evans, Muhammad Hasan, Laurent Galibert, et al.
Vaccine|November 22, 2002
Synthetic AIDS vaccine by targeting HIV receptorChang Yi Wang, Ming Shen, Gary Tam, et al.
Vaccine|November 22, 2002
The assessment of OPV vaccines by the monkey neurovirulence test: why and how to qualify the experts in histology of central nervous systemBertrand Poirier, Sylvie Morgeaux, Florence Fuchs
Vaccine|November 22, 2002
CpG-containing oligodeoxynucleotides, in combination with conventional adjuvants, enhance the magnitude and change the bias of the immune responses to a herpesvirus glycoproteinX P Ioannou, S M Gomis, B Karvonen, et al.
Vaccine|June 12, 2002
A dilemma for mucosal vaccination: efficacy versus toxicity using enterotoxin-based adjuvantsKohtaro Fujihashi, Toshiya Koga, Frederik W van Ginkel, et al.
Vaccine|June 12, 2002
Recombinant cysteine proteinases-based vaccines against Leishmania major in BALB/c mice: the partial protection relies on interferon gamma producing CD8(+) T lymphocyte activationSima Rafati, Amina Kariminia, Shiva Seyde-Eslami, et al.
Pageof 2,772